All News

Renewable energy sources accounted for an impressive 62 per cent of the new electricity generation capacity installed in the EU in 2009, says a new report.

Two of the UK’s leading medical research funders are pooling resources in an attempt to bridge the gap between the research they fund and commercialisable technology.

The Science|Business Innovation Board, meeting with EU Research Commissioner Geoghegan-Quinn, warns against cuts in national R&D budgets in the downturn.

AstraZeneca and the Medicines for Malaria Venture have announced a collaboration to identify novel candidate drugs for the treatment of malaria.

SV Life Sciences has announced the final closing of its newest fund, SV Life Sciences Fund V, at over $523 million, well exceeding its target of $400 million.

The Commission wants to see a charging system for electric cars, scooters and bikes that will allow any vehicle to be recharged in any member state.

A lack of clarity over the patentability of therapies developed from stem cells is holding back European research in the field, according to a new report.

Silicon Valley and Boston aren’t the only areas looking for new ways to innovate, as Midwest ‘rust belt’ states set out new strategies.

Innovation is not just about ‘light bulb’ moments of creativity, but requires strategic leadership, according to a new report sponsored by the UK government.